Posted by Michael Wonder on 01 Feb 2023
Mark Cuban Cost Plus Drug Company and OncoPower team up to bring medication adherence and cost savings to cancer patients
30 January 2023 - Collaboration focuses on pricing transparency, affordable access, and engaging patients at home to ensure treatment adherence.
The Mark Cuban Cost Plus Drug Company, PBC and OncoPower, announce a collaboration to build on OncoPower’s cancer care support with the launch of a Medication Savings Suite, which leverages Cost Plus Drugs competitive pricing on generic medication to seamlessly allow the cancer patients that use OncoPower to look up pricing and order less expensive medications.
